69.50
전일 마감가:
$68.31
열려 있는:
$68
하루 거래량:
9,023
Relative Volume:
0.50
시가총액:
$193.61M
수익:
$23.93M
순이익/손실:
$-3.41M
주가수익비율:
-60.96
EPS:
-1.14
순현금흐름:
$-33.87M
1주 성능:
+19.83%
1개월 성능:
+64.99%
6개월 성능:
+732.34%
1년 성능:
+472.77%
Sol Gel Technologies Ltd Stock (SLGL) Company Profile
SLGL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SLGL
Sol Gel Technologies Ltd
|
69.50 | 190.30M | 23.93M | -3.41M | -33.87M | -1.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-19 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2022-10-21 | 재개 | Jefferies | Hold |
| 2019-12-31 | 재확인 | H.C. Wainwright | Buy |
| 2019-12-31 | 재확인 | JMP Securities | Mkt Outperform |
Sol Gel Technologies Ltd 주식(SLGL)의 최신 뉴스
Sol-Gel Technologies: Downgrading To 'Hold' As Success Relies On Upcoming Q4 Catalyst - Seeking Alpha
Bear Alert: Can Falcons Beyond Global Inc deliver consistent dividendsTrade Performance Summary & Fast Momentum Entry Tips - baoquankhu1.vn
Here's Why We're Not At All Concerned With Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation - simplywall.st
Value Recap: Is Sol Gel Technologies Ltd. undervalued by DCF analysisQuarterly Risk Review & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Inflation Data: Can Sol Gel Technologies Ltd beat the S P 500Weekly Profit Recap & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Short Interest in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Declines By 67.2% - MarketBeat
How rising interest rates impact Sol Gel Technologies Ltd. stockJuly 2025 PostEarnings & Low Risk Entry Point Guides - Улправда
Aug Weekly: Will Sol Gel Technologies Ltd. stock gain from lower inflation2025 Top Gainers & Real-Time Chart Pattern Alerts - Улправда
Support Test: How Sol Gel Technologies Ltd. stock reacts to bond yieldsJuly 2025 WrapUp & Expert-Curated Trade Recommendations - Улправда
Can Sol Gel Technologies Ltd. stock hit record highs againJuly 2025 Reactions & Precise Buy Zone Tips - Улправда
Is Sol Gel Technologies Ltd. stock supported by strong cash flowsJuly 2025 Chart Watch & Consistent Return Investment Signals - ulpravda.ru
How Sol Gel Technologies Ltd. stock reacts to bond yieldsJuly 2025 Fed Impact & AI Powered Buy/Sell Recommendations - ulpravda.ru
Does Sol Gel Technologies Ltd. stock trade at a discount to peersTrade Signal Summary & Short-Term High Return Ideas - Улправда
Can MMP Industries Limited Regain Lost Ground This QuarterStock Liquidity Analysis & Stay Ahead With Daily Market Discussions - bollywoodhelpline.com
Siddhika Coating Limited A Paint CompanyStock Rotation Strategies & Build Diversified Portfolios With Ease - bollywoodhelpline.com
Opaleye Management Inc. Increases Stake in Sol-Gel Technologies Ltd - GuruFocus
Rosacea Market Research and Forecast Report 2025-2035: Galderma, AbbVie, Bausch Health, Journey Medical, and Sol-Gel Drive Innovation Through Expanded R&D and Clinical TrialsResearchAndMarkets.com - The AI Journal
FinancialContentRosacea Market Research and Forecast Report 2025-2035: Galderma, AbbVie, Bausch Health, Journey Medical, and Sol-Gel Drive Innovation Through Expanded R&D and Clinical TrialsResearchAndMarkets.com - FinancialContent
Opaleye Management Inc. Buys 22,497 Shares of Sol-Gel Technologies (NASDAQ:SLGL) Stock - Defense World
Opaleye Management Inc. Acquires 35,169 Shares of Sol-Gel Technologies (NASDAQ:SLGL) Stock - Defense World
Market Moves: Why Sol Gel Technologies Ltd stock could see breakout soonAnalyst Upgrade & Weekly Top Stock Performers List - Bộ Nội Vụ
Weekly Analysts’ Ratings Changes for Sol-Gel Technologies (SLGL) - Defense World
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Purchases $361,500.30 in Stock - MarketBeat
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Opaleye Management Inc. Purchases 35,169 Shares of Stock - MarketBeat
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Buys $944,649.03 in Stock - MarketBeat
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Purchases $10,831.60 in Stock - MarketBeat
Insider Buying: Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Buys 1,019 Shares of Stock - MarketBeat
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Purchases $67,771.68 in Stock - MarketBeat
We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Easily Afford To Drive Business Growth - Yahoo Finance
Sol-Gel Technologies (SLGL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
What is HC Wainwright's Estimate for SLGL FY2025 Earnings? - MarketBeat
What analysts say about Sol Gel Technologies Ltd stockAI-Driven Market Analysis & Small Investment Capital Gains - earlytimes.in
Sol-Gel Technologies’ (SLGL) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Sol-Gel Technologies (NASDAQ:SLGL) Receives "Buy" Rating from HC Wainwright - MarketBeat
HC Wainwright & Co. Reiterates Sol-Gel Technologies (SLGL) Buy Recommendation - Nasdaq
SLGL: HC Wainwright & Co. Reiterates Buy Rating with $50 Price T - GuruFocus
What dividend safety score for Sol Gel Technologies Ltd. stockWeekly Market Summary & Free Community Supported Trade Ideas - Улправда
Will Sol Gel Technologies Ltd. stock gain from lower inflationJuly 2025 WrapUp & Community Shared Stock Ideas - Улправда
Insider Buying: Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Acquires 2,735 Shares of Stock - MarketBeat
Owner Opaleye Management Inc Buys 2,735 ($110.4K) Of Sol-Gel Technologies Ltd [SLGL] - TradingView — Track All Markets
How analysts rate Sol Gel Technologies Ltd. stock todayJuly 2025 Chart Watch & Fast Entry High Yield Tips - bolumsonucanavari.com
Is Sol Gel Technologies Ltd. stock a buy before product launchesQuarterly Profit Report & Daily Technical Forecast Reports - DonanımHaber
Why Sol Gel Technologies Ltd. stock could see breakout soonMarket Trend Review & Consistent Profit Alerts - DonanımHaber
Will Sol Gel Technologies Ltd. stock benefit from upcoming earnings reports2025 Valuation Update & Safe Capital Growth Plans - Улправда
Sol-Gel Technologies (SLGL) FDA Approvals, PDUFA Dates & Drug Alerts 2025 - MarketBeat
Sol-Gel to End SGT-210 Trial in Darier Disease - marketscreener.com
Sol-Gel halts Darier disease treatment after failed clinical trial By Investing.com - Investing.com Nigeria
Why Is Small Cap Sol-Gel Tech Stock Falling Today? - Benzinga
Sol-Gel Technologies Updates Clinical Pipeline Following Phase 1b Results - TipRanks
Sol-Gel Technologies (SLGL) files update on SGT-210 Darier Phase 1b - Stock Titan
Sol-Gel halts studies for rare disease drug (SLGL:NASDAQ) - Seeking Alpha
Sol Gel Technologies Ltd (SLGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Sol Gel Technologies Ltd 주식 (SLGL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Jan 02 '26 |
Buy |
41.92 |
2,394 |
100,348 |
447,133 |
| Opaleye Management Inc. | 10% Owner |
Jan 05 '26 |
Buy |
42.98 |
198 |
8,510 |
447,331 |
| Opaleye Management Inc. | 10% Owner |
Dec 30 '25 |
Buy |
41.99 |
35,169 |
1,476,627 |
421,242 |
| Opaleye Management Inc. | 10% Owner |
Dec 31 '25 |
Buy |
41.99 |
22,497 |
944,744 |
443,739 |
| Opaleye Management Inc. | 10% Owner |
Dec 29 '25 |
Buy |
41.85 |
8,638 |
361,534 |
386,073 |
| Opaleye Management Inc. | 10% Owner |
Dec 26 '25 |
Buy |
41.68 |
1,626 |
67,765 |
377,435 |
| Opaleye Management Inc. | 10% Owner |
Dec 22 '25 |
Buy |
41.15 |
1,019 |
41,936 |
375,549 |
| Opaleye Management Inc. | 10% Owner |
Dec 23 '25 |
Buy |
41.66 |
260 |
10,832 |
375,809 |
| Opaleye Management Inc. | 10% Owner |
Dec 17 '25 |
Buy |
40.37 |
2,735 |
110,412 |
374,530 |
| Opaleye Management Inc. | 10% Owner |
Dec 12 '25 |
Buy |
40.00 |
87 |
3,480 |
371,795 |
자본화:
|
볼륨(24시간):